114 related articles for article (PubMed ID: 8677295)
1. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk.
Land CE; Saku T; Hayashi Y; Takahara O; Matsuura H; Tokuoka S; Tokunaga M; Mabuchi K
Radiat Res; 1996 Jul; 146(1):28-36. PubMed ID: 8677295
[TBL] [Abstract][Full Text] [Related]
2. Salivary gland tumors among atomic bomb survivors, 1950-1987.
Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
[TBL] [Abstract][Full Text] [Related]
3. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
[TBL] [Abstract][Full Text] [Related]
4. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
Little MP
Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
[TBL] [Abstract][Full Text] [Related]
8. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
Wakabayashi T; Kato H; Ikeda T; Schull WJ
Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504
[TBL] [Abstract][Full Text] [Related]
9. Gamma radiation sensitivity and risk of malignant and benign salivary gland tumors: a pilot case-control analysis.
Zheng R; Wang LE; Bondy ML; Wei Q; Sturgis EM
Cancer; 2004 Feb; 100(3):561-7. PubMed ID: 14745873
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships.
Schneider AB; Lubin J; Ron E; Abrahams C; Stovall M; Goel A; Shore-Freedman E; Gierlowski TC
Radiat Res; 1998 Jun; 149(6):625-30. PubMed ID: 9611101
[TBL] [Abstract][Full Text] [Related]
11. Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80.
Tokuoka S; Kawai K; Shimizu Y; Inai K; Ohe K; Fujikura T; Kato H
J Natl Cancer Inst; 1987 Jul; 79(1):47-57. PubMed ID: 3474449
[TBL] [Abstract][Full Text] [Related]
12. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
[TBL] [Abstract][Full Text] [Related]
13. Understanding estimation of time and age effect-modification of radiation-induced cancer risks among atomic-bomb survivors.
Lagarde F
Health Phys; 2006 Dec; 91(6):608-18. PubMed ID: 17099404
[TBL] [Abstract][Full Text] [Related]
14. Profiles of non-cancer diseases in atomic bomb survivors.
Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
[TBL] [Abstract][Full Text] [Related]
15. Comment on "Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk" by Land et al. (Radiat. Res. 146, 28-36, 1996).
Pogoda JM; Preston-Martin S
Radiat Res; 1996 Sep; 146(3):356. PubMed ID: 8752317
[No Abstract] [Full Text] [Related]
16. Male breast cancer incidence among atomic bomb survivors.
Ron E; Ikeda T; Preston DL; Tokuoka S
J Natl Cancer Inst; 2005 Apr; 97(8):603-5. PubMed ID: 15840883
[TBL] [Abstract][Full Text] [Related]
17. Tumors of the major and minor salivary glands: review of 25 years of experience.
Nagler RM; Laufer D
Anticancer Res; 1997; 17(1B):701-7. PubMed ID: 9066605
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
Little MP
Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
[TBL] [Abstract][Full Text] [Related]
19. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
Little MP
Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
[TBL] [Abstract][Full Text] [Related]
20. Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992.
Delongchamp RR; Mabuchi K; Yoshimoto Y; Preston DL
Radiat Res; 1997 Mar; 147(3):385-95. PubMed ID: 9052687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
